Trademark Overview
On Wednesday, June 17, 2026, a trademark application was filed for INUBLISO with the United States Patent and Trademark Office. The USPTO has given the INUBLISO trademark a serial number of 99890622. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, June 17, 2026. This trademark is owned by Johnson & Johnson. The INUBLISO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Medical apparatus for introducing pharmaceutical preparations into the human body; implantable medical device for introducing pharmaceutical preparations into the human body; implantable drug delivery device
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders